Attached files

file filename
EX-23.1 - EX-23.1 - FINJAN HOLDINGS, INC.b81669exv23w1.htm
EX-99.1 - EX-99.1 - FINJAN HOLDINGS, INC.b81669exv99w1.htm
EX-99.2 - EX-99.2 - FINJAN HOLDINGS, INC.b81669exv99w2.htm
8-K/A - 8-K/A AMENDMENT NO. 2 - FINJAN HOLDINGS, INC.b81669e8vkza.htm
Exhibit 99.3
INDEX
TERRASPHERE SYSTEMS LLC.
CONVERTED ORGANICS INC.
         
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
       
 
Introduction
       
 
Unaudited Pro Forma Consolidated Balance Sheet as of March 31, 2010
       
 
Unaudited Pro Forma Consolidated Statements of Operations and Comprehensive Income (Loss) for the three month period ended March 31, 2010
       
 
Unaudited Pro Forma Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2009
       
 
Notes to Unaudited Pro Forma Consolidated Financial Statements
       

 


 

 
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
 
Introduction
 
On July 6, 2010, Converted Organics Inc. (the “Company”) and its wholly-owned subsidiary TerraSphere Inc. entered into a membership interest purchase agreement (“Agreement”) with TerraSphere Systems LLC to acquire 100% of the membership interests in TerraSphere Systems LLC (“TerraSphere”) subject to, among other items, the Company’s shareholder approval. This acquisition enables the Company to license TerraSphere’s patented Growth System, which is a system of modules and processes for growing plants in a controlled environment. The system uses and controls precise combinations of light, water, nutrition, gravity, centrifugal forces, and gasses to produce growing conditions that can be controlled and manipulated to result in desired plant growth and maximum crop production.
 
Terms
 
The Agreement allows for an election by TerraSphere members to accept 1) a purchase price of $21,000,000 of Company common stock upon closing of the transaction (with a 6 month holding period) (“Option One”) or 2) a purchase price of $12,000,000 of Company common stock upon closing of the transaction with an option to earn an additional $16,000,000 in contingent consideration based upon TerraSphere achieving certain milestones and agreeing to an 18 month holding period on stock distributed to them (“Option Two”). Based on 31% of TerraSphere members’ electing Option One and 69% electing Option Two, the maximum total purchase price is $25,830,000 payable in the Company’s common stock valued at $0.756 per share. Per the Agreement, TerraSphere members who elected Option One will receive $6,510,000 upon closing and members electing Option Two will receive $8,280,000 upon closing and up to an additional $11,040,000 based on achieving the defined milestones (contingent consideration).
 
Milestone One Payment:  $3,450,000 of Company common stock, if, and only if, between the date of the Agreement and the 90th day following the closing date or the 180th day following the date of the Agreement, the following occurs (such shares to be payable within ten (10) business days of achievement of the following or the closing date, whichever is later): For a period of five (5) consecutive trading days, the Company’s market capitalization exceeds the sum of: (1) the Company’s initial market capitalization on the date of execution of the Agreement, plus (2) the closing price per share, or $0.756, multiplied by the number of shares of Company common stock to be issued at closing pursuant to the Agreement, and, if such calculation is being made prior to the closing date, including this Milestone One. If between the date of the Agreement and the 90th day following the closing date or the 180th day following the date of the Agreement, the Company completes an equity financing, the cash received from the equity financing during such period shall be added to the market capitalization. If between the closing date and December 31, 2011, the Buyer sells equity of either the Company or any of the Company’s subsidiaries, any cash received from such equity sales during such period shall be added to the market capitalization;
 
Milestone Two Payment:  $1,380,000 of Company common stock, if, and only if, $2,000,000 of TerraSphere’s accounts receivable as of the date of the Agreement are received prior to February 28, 2011;
 
Milestone Three Payment:  $3,450,000 of Company common stock, if, and only if, the Company generates gross margin of $6,000,000 (gross margin target) from its operations during the period commencing as of the date of the Agreement and ending on December 31, 2011; provided that, if the Company generates gross margin of at least $4,200,000 (gross margin threshold) from its operations during such period, the Sellers shall be entitled to a pro rata portion of the Company common stock; and
 
Milestone Four Payment:  $2,760,000 of Company common stock, if, and only if, the Company generates gross margin of $4,000,000 from its operations during any six-month period commencing on the Agreement date and ending on December 31, 2012; provided that, if the Company achieves the Milestone Three gross margin threshold, but does not achieve the Milestone Three gross margin target, 83.3% of the difference between the Milestone Three gross margin target and the actual gross margins achieved pursuant to the Agreement (the “Milestone Three Deficiency”) may be added by the Sellers to the Milestone Four Payment and the Milestone Four gross margin target. Notwithstanding anything to the contrary herein, the total


 


 

amounts payable pursuant to the Milestone Three Payment and Milestone Four Payment shall be no more than $6,210,000 of Company common stock.
 
The Company used the following assumptions to calculate fair value of the contingent consideration:
 
Milestone One:  The acquisition of TerraSphere will diversify the Company’s base while still sustaining business practices that protect and value the environment, current customers, colleagues, and shareholders. The likelihood of meeting this milestone is largely dependent on the state of the U.S. economy and future market conditions, both of which are uncertain and unpredictable. If the U.S. economy becomes stagnant or the market conditions are not favorable for investors, the Company may not achieve this milestone. Based on the uncertainty of the U.S. economy and the unpredictability of the market over the next 6-12 months, the Company has estimated that the likelihood of achieving this milestone is 75% and, as such, has determined that the fair value of this contingent payment is $2,588,000.
 
Milestone Two:  The Company has reviewed the customers’ credit worthiness and ability to make the required installment payments. Based on this information, the Company has estimated that the likelihood of achieving this milestone is 95% and, as such, has determined that the fair value of this contingent payment is $1,311,000.
 
Milestones Three and Four:  The Company has evaluated milestones three and four together as they can be achieved over the same milestone period. The Company has reviewed TerraSphere’s operating estimates and historical data and believes these milestones are achievable. TerraSphere’s plans are based on the U.S. economy continuing to grow at a steady rate, investors investing in new technology and market acceptance of the Growth System technology. If the U.S. economy becomes stagnant or the market conditions are not favorable or the technology is not well received during the milestone periods, the Company may not achieve the milestones. Based on the uncertainty of the U.S. economy and the unpredictability of the market over the next 36 months, the Company has estimated that the likelihood of achieving milestones three and four is 50% and as such, has determined that the fair value of these contingent payments is $3,105,000.
 
The estimated purchase price at fair value is as follows:
 
         
Election of Option One
  $ 6,510,000  
Election of Option Two
    8,280,000  
Milestone one payment
    2,588,000  
Milestone two payment
    1,311,000  
Milestones three and four payments
    3,105,000  
         
    $ 21,794,000  
         
 
The following unaudited pro forma consolidated financial information gives effect to the Company acquiring 100% of the membership interests in TerraSphere Systems, LLC and should be read in conjunction with the Company’s Form 8-K dated July 6, 2010 and filed on July 7, 2010, the historical financial statements and the related notes of Converted Organics Inc., which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009, the quarterly financial statements and the related notes of Converted Organics, Inc., which are included in the Company’s Form 8-K as of March 31, 2010, the TerraSphere Systems, LLC financial statements which are included in this proxy statement.
 
The unaudited pro forma consolidated balance sheet as of March 31, 2010 gives effect to the acquisition of TerraSphere Systems, LLC transaction as if it had occurred on March 31, 2010, and the unaudited pro forma consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2009 and for the three month period ended March 31, 2010 give effect to the acquisition as if it had occurred on January 1, 2009.


 


 

The unaudited pro forma consolidated financial statements include all material pro forma adjustments necessary for their preparation, as required by Article 11 of Regulation S-X and, accordingly, do not assume any benefits from cost savings or synergies of operations.
 
The pro forma adjustments are based upon available information and certain assumptions that the Company believes are reasonable. The unaudited pro forma consolidated financial statements do not purport to represent what the Company’s financial condition or results of operations would actually have been had these transactions in fact occurred as of the dates indicated above or to project the Company’s results of operations for the period indicated or for any other period.
 
Changes in the fair value of contingent consideration that the Company recognizes after the acquisition date may be the result of additional information about facts and circumstances that existed at the acquisition date that the Company obtained after that date. Such changes are considered to be measurement period adjustments and would adjust the purchase price for changes within one year from the acquisition date. Contingent consideration classified as an asset or a liability that exceed a year from the acquisition date is remeasured at fair value and recognized in earnings.


 


 

 
CONVERTED ORGANICS INC.
 
AS OF MARCH 31, 2010
 
                                 
    Historical     Pro
          Pro
 
    Converted Organics
    Forma
          Forma
 
    Inc. and Subsidiaries     Adjustments     Reference     Consolidated  
 
ASSETS
CURRENT ASSETS
                               
Cash and cash equivalents
  $ 4,113,359     $ 106,830       (1 )   $ 4,220,189  
Restricted cash
    233,316                     233,316  
Accounts receivable, net
    495,450       950,000       (1 )     1,445,450  
Inventories
    371,301                     371,301  
Prepaid rent
    641,781                     641,781  
Other prepaid expenses
    624,319       106,521       (1 )     730,840  
                                 
Total current assets
    6,479,526       1,163,351               7,642,877  
                                 
Deposits
    800,419       5,886       (1 )     806,305  
Restricted cash
    29,769                     29,769  
Other assets
    166,667                     166,667  
Property and equipment, net
    18,382,828       158,819       (1 )     18,541,647  
Construction-in-progress
    328,637       81,017       (1 )     409,654  
Capitalized bond costs, net
    802,424                     802,424  
Intangible assets, net
    1,923,617       10,000,000       (1 )     11,923,617  
Goodwill
          12,370,000       (1 )     12,370,000  
                                 
Total assets
  $ 28,913,887     $ 23,779,073             $ 52,692,960  
                                 
 
LIABILITIES AND OWNERS’ EQUITY (DEFICIT)
CURRENT LIABILITIES
                               
Term notes payable — current
  $ 1,812,764     $ 184,351       (1 )   $ 1,997,115  
Accounts payable
    1,150,770       1,353,304       (1 )     2,504,074  
Accrued compensation, officers, directors and consultants
    455,218                     455,218  
Accrued legal and other expenses
    708,095       12,834       (1 )     720,929  
Accrued interest
    249,191                     249,191  
Deferred revenue
          434,584       (1 )     434,584  
Convertible notes payable, net of unamortized discount
    286,450                     286,450  
Capital lease obligations — current
    12,069                     12,069  
                                 
Total current liabilities
    4,674,557       1,985,073               6,659,630  
                                 
Capital lease obligation, net of current portion
    25,654                     25,654  
Term notes payable, net of current portion
    509,833                     509,833  
Derivative liabilities
    2,261,897                     2,261,897  
Bonds payable
    17,500,000                     17,500,000  
                                 
Total liabilities
    24,971,941       1,985,073               26,957,014  
                                 
COMMITMENTS AND CONTINGENCIES
                         
OWNERS’ EQUITY (DEFICIT)
                               
Preferred stock, $.0001 par value, authorized
                               
10,000,000 shares; no shares issued and outstanding
                         
Common stock, $.0001 par value, authorized 75,000,000 shares
    3,802       1,852       (1 )     5,654  
Additional paid-in capital
    60,209,902       21,792,148       (1 )     82,002,050  
Accumulated deficit
    (56,271,758 )                   (56,271,758 )
                                 
Total owners’ equity
    3,941,946       21,794,000               25,735,946  
                                 
Total liabilities and owners’ equity
  $ 28,913,887     $ 23,779,073             $ 52,692,960  
                                 
 
The accompanying notes are an integral part of these unaudited pro forma consolidated financial statements.


 


 

 
                                 
    Historical                  
    Converted Organics
    Pro Forma
        Pro Forma
 
    Inc. and Subsidiaries     Adjustments     Reference   Consolidated  
 
Revenues
  $ 859,826     $ 1,684,183       (2)     $ 2,544,009  
Cost of good sold
    1,966,101       703,301       (2)       2,669,402  
                             
Gross loss
    (1,106,275 )     980,882               (125,393 )
Operating expenses
                               
General and administrative expenses
    4,089,501       436,998       (2)       4,526,499  
Research and development
    64,059             (2)       64,059  
Depreciation expense
    2,819                     2,819  
Amortization of capitalized costs
    75,371       177,484       (2),(3)       252,855  
Amortization of license
    8,548                     8,548  
                             
Loss from operations
    (5,346,573 )     366,400               (4,980,173 )
                             
Other income/(expenses)
                               
Interest income
    281                     281  
Derivative gain/(loss)
    (635,155 )                   (635,155 )
Other income
          17,190       (2)       17,190  
Interest expense
    (398,246 )     (3,905 )     (2)       (402,151 )
                             
      (1,033,120 )     13,285               (1,019,835 )
                             
Loss before provision for income taxes
    (6,379,693 )     379,685               (6,000,008 )
Provision for income taxes
                         
                             
Net loss
    (6,379,693 )     379,685               (6,000,008 )
Net income (loss) attributable to noncontrolling interest
          (117,507 )     (2)       (117,507 )
                             
Net income (loss) attributable to Converted Organics Inc. before other comprehensive income (loss)
    (6,379,693 )     497,192               (5,882,501 )
Other comprehensive income (loss):
                               
Foreign currency translation adjustment
          (41,766 )     (2)       (41,766 )
                             
Comprehensive income (loss)
    (6,379,693 )     455,426               (5,924,267 )
Comprehensive income (loss) attributable to noncontrolling interest
          (6,264 )     (2)       (6,264 )
                             
Comprehensive income (loss) attributable to Converted Organics Inc. 
  $ (6,379,693 )   $ 461,690             $ (5,918,003 )
                             
Net loss per share, basic and diluted
  $ (0.17 )             (4)     $ (0.10 )
                             
Weighted average common shares outstanding
    37,864,169               (4)       56,389,068  
                             
 
The accompanying notes are an integral part of these unaudited pro forma consolidated financial statements.


 


 

 
                                 
    Historical                  
    Converted Organics
    Pro Forma
        Pro Forma
 
    Inc. and Subsidiaries     Adjustments     Reference   Consolidated  
 
Revenues
  $ 2,633,782     $ 36,732       (2)     $ 2,670,514  
Cost of good sold
    6,914,857                     6,914,857  
                             
Gross loss
    (4,281,075 )     36,732               (4,244,343 )
Operating expenses
                               
General and administrative expenses
    10,049,830       1,291,586       (2)       11,341,416  
Research and development
    637,142       613       (2)       637,755  
Depreciation expense
    723,846                     723,846  
Amortization of capitalized costs
    357,718       673,050       (2),(3)       1,030,768  
Amortization of license
    16,500                     16,500  
                             
Loss from operations
    (16,066,111 )     (1,928,517 )             (17,994,628 )
                             
Other income/(expenses)
                               
Interest income
    24,097                     24,097  
Loss on impairment of long-term assets
    (3,928,129 )                   (3,928,129 )
Derivative gain/(loss)
    5,766,035                     5,766,035  
Other income
    68,995       55,114       (2)       124,109  
Interest expense
    (6,970,675 )     (9,218 )     (2)       (6,979,893 )
                             
      (5,039,677 )     45,896               (4,993,781 )
                             
Loss before provision for income taxes
    (21,105,788 )     (1,882,621 )             (22,988,409 )
Provision for income taxes
                         
                             
Net loss
    (21,105,788 )     (1,882,621 )             (22,988,409 )
Net income (loss) attributable to noncontrolling interest
          74,934       (2)       74,934  
                             
Net income (loss) attributable to Converted Organics Inc. before other comprehensive income (loss)
    (21,105,788 )     (1,957,555 )             (23,063,343 )
Other comprehensive income (loss):
                               
Foreign currency translation adjustment
          (57,491 )     (2)       (57,491 )
                             
Comprehensive income (loss)
    (21,105,788 )     (2,015,046 )             (23,120,834 )
Comprehensive income (loss) attributable to noncontrolling interest
          (8,623 )     (2)       (8,623 )
                             
Comprehensive income (loss) attributable to Converted Organics Inc. 
  $ (21,105,788 )   $ (2,006,423 )           $ (23,112,211 )
                             
Net loss per share, basic and diluted
  $ (1.08 )             (4)     $ (0.61 )
                             
Weighted average common shares outstanding
    19,569,853               (4)       38,114,781  
                             
 
The accompanying notes are an integral part of these unaudited pro forma consolidated financial statements.


 


 

CONVERTED ORGANICS INC.
 
 
The following numbered notes are referenced on the Unaudited Pro Forma Consolidated Balance Sheet and Statements of Operations and Comprehensive Income (Loss).
 
(1)  The Company purchased 100% of the membership interests in TerraSphere Systems, LLC, for consideration and contingent consideration with an estimated fair value of $21,794,000 all consideration is to be paid in the Company’s common stock.
 
The estimated purchase price has been allocated to the assets and liabilities on a preliminary basis using estimated fair value information currently available. The allocation of the purchase price to the assets and liabilities will be finalized within a year as the Company obtains more information regarding asset valuations, liabilities assumed, contingent consideration and revisions of preliminary estimates of fair value made as the date of purchase. The preliminary purchase price allocation is as follows:
 
         
Cash and cash equivalents
  $ 106,830  
Accounts receivable
    950,000  
Other assets
    112,407  
Leasehold improvements
    158,819  
Construction-in-process
    81,017  
Goodwill
    12,370,000  
Patents and patent related costs
    10,000,000  
Assumption of liabilities
    (1,985,073 )
         
Total allocation of purchase price(*)
  $ 21,794,000  
         
 
The Company plans to amortize the leasehold improvements over their estimated service lives or the remaining terms of the related leases, whichever are shorter. Patents and patent related costs will be amortized over the 15 year remaining life of the patents.
 
(*) The purchase price of $21,794,000 is an estimate based on the assumptions listed in the “Unaudited Pro Forma Condensed Combined Financial Statements” section of this document. Actual results could vary significantly from this estimate. Any adjustments within one year would adjust the purchase price. Adjustments after one year of the acquisition date are remeasured to fair value at each reporting date until the contingency is resolved and the changes in fair value are recognized in earnings in accordance with ASC 805 “Business Combinations”.
 
(2) The operations of TerraSphere Systems, LLC are consolidated with the operations of Converted Organics Inc. assuming that the transaction was completed on January 1, 2009.
 
(3) Amortization expense related to the fair value assigned to the patent and patent related costs.
 
(4) Earnings per share has been recalculated to reflect the number of common stock shares issued in acquiring TerraSphere.